India Point of Care Diagnostics Market 2025-2033
According to IMARC Group’s report titled “India Point of Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End User, and Region, 2025-2033“, The report offers a comprehensive analysis of the industry, including market share, growth, trends, and regional insights.
How Big is the India Point of Care Diagnostics Industry ?
The India point of care diagnostics market size was valued at USD 1.35 Million in 2024 and is expected to reach USD 2.98 Million by 2033, exhibiting a CAGR of 8.74% during 2025-2033.
India Point of Care Diagnostics Market Trends:
The Indian POC diagnostics market is undergoing rapid changes, brought upon by technological innovations on one side, and rapidly evolving healthcare demand on the other. Following a new trend of portability and utmost usability to get results without delay, these devices are used in decentral settings such as clinics, pharmacies, and more recently, even homes. The incorporation of AI and IoT has brought yet another evolution to POC diagnostics, wherein smart devices can analyze data in real time and provide remote monitoring. The increasing incidence of chronic ailments such as diabetes and cardiovascular problems offers yet another avenue for quick testing solutions that give instantaneous clinical insight. Also, prevention-based healthcare stimulates the market growth-way preventions wherein the consumer increasingly considers early detection and wellness monitoring.
In the recent past, telemedicine expansion was creating synergy with POC diagnostics in which a healthcare provider is able to complete virtual consultations with instant test results. Notably, the development of multiplex testing devices capable of detecting multiple analytes from a single sample is gaining traction, improving diagnostic efficiency. The market is also witnessing increased focus on user-friendly designs, catering to non-specialized users in rural and semi-urban areas. Additionally, strategic collaborations between diagnostic companies and tech startups are fostering innovation in affordable, scalable POC solutions tailored to India’s diverse healthcare landscape.
Request for a sample copy of this report: https://www.imarcgroup.com/india-point-of-care-diagnostics-market/requestsample
India Point of Care Diagnostics Market Scope and Growth Analysis:
The POC diagnostics market in India offers major opportunities for expansion, supported by growing healthcare infrastructure and rising health consciousness. Moreover, the huge potential still untapped in tier-2 and tier-3 cities offers great opportunities for market penetration with increased healthcare access promoting demand for decentralized test solutions. Further, government impetus in universal health coverage will augment adoption, promoting an environment with policies to emphasize affordable and accessible diagnostic tools. On the other hand, the rising burden imposed by infectious diseases demands a need for rapid diagnostic solutions, elevating the position of POC devices as essential tools for prompt disease management.
Currently, glucose monitoring commands the major share of demand, while infectious disease testing and pregnancy diagnostics are anticipated to register fastest growth owing to their clinical urgency and wide applicability. The market is further aided by recent advances in microfluidics and biosensor technologies, which have given rise to enhanced POC devices with greater accuracy and cost benefits. With rising investments in healthcare digitization and the expansion of diagnostic networks, India’s POC diagnostics sector is poised for robust expansion, aligning with global trends toward patient-centric, decentralized healthcare delivery models.
We explore the factors propelling the India point of care diagnostics market growth, including technological advancements, consumer behaviors, and regulatory changes.
India Point of Care Diagnostics Industry Segmentation:
The report has segmented the market into the following categories:
Analysis by Product Type:
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Analysis by Platform:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Analysis by Prescription Mode:
- Prescription-based Testing
- OTC Testing
Analysis by End User:
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Regional Analysis:
- North India
- West and Central India
- South India
- East and Northeast India
Competitor Landscape:
The report offers an in-depth examination of the competitive landscape. It includes a thorough competitive analysis encompassing market structure, key player positioning, leading strategies for success, a competitive dashboard, and a company evaluation quadrant.
Other key areas covered in the report:
- COVID-19 Impact on the Market
- Porter’s Five Forces Analysis
- Strategic Recommendations
- Market Dynamics
- Historical, Current and Future Market Trends
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain Analysis
- Comprehensive Mapping of the Competitive Landscape
- Top Winning Strategies
- Recent Industry News
- Key Technological Trends & Development
Ask an analyst: https://www.imarcgroup.com/request?type=report&id=21343&flag=C
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
About Us:
IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services.
IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
Leave a Reply